Molecular medicine (Cambridge, Mass.) · 2026
Hydrogen sulfide-mediated protein s-persulfidation: a regulatory mechanism in cardiovascular homeostasis.
СтатьяОбзорПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Luzheng, Gu Ziyi, Xue Song, Wang Yongyi
Аннотация
BACKGROUND: Cardiovascular diseases represent a primary cause of global mortality. Hydrogen sulfide operates as a major endogenous gasotransmitter that contributes to cardiovascular homeostasis through multiple biochemical mechanisms, among which protein S-persulfidation, represents a major redox-sensitive post-translational mechanism. This dynamically reversible modification converts cysteine sulfhydryl groups into highly nucleophilic persulfide groups to prevent irreversible oxidative damage.
AIM OF REVIEW: This review aims to systematically synthesize the current molecular understanding of S-persulfidation in cardiovascular biology. We evaluate the methodological evolution of site-specific detection technologies, delineate the regulatory mechanisms of sulfur signaling across distinct physiological axes, and assess the clinical translational potential of reactive sulfur species delivery systems.
KEY SCIENTIFIC CONCEPTS OF REVIEW: The manuscript outlines the evolution of detection methodologies from early biotin-switch assays to Quantitative Thiol Reactivity Profiling. Mechanistically, S-persulfidation modulates membrane potential and vascular tone by altering the open probability of ion channels including KATP and Cav1.2. At the intracellular level, this modification regulates kinase cascades, redox sensors such as the Keap1/Nrf2 pathway, and metabolic enzymes to preserve mitochondrial bioenergetics. S-persulfidation also orchestrates genomic and post-transcriptional programs by directly modifying transcription factors and RNA-binding proteins. Furthermore, it reinforces the cellular protein quality control system to alleviate endoplasmic reticulum stress, optimize autophagy, and establish inhibitory checkpoints against apoptosis and pyroptosis. The review also evaluates systemic delivery vectors, including S-persulfidated albumin and engineered biomaterial scaffolds. Overcoming current translational barriers requires integrating spatial multi-omics with site-specific genetic validation to advance S-persulfidation biology toward precise cardiovascular therapeutics.
AIM OF REVIEW: This review aims to systematically synthesize the current molecular understanding of S-persulfidation in cardiovascular biology. We evaluate the methodological evolution of site-specific detection technologies, delineate the regulatory mechanisms of sulfur signaling across distinct physiological axes, and assess the clinical translational potential of reactive sulfur species delivery systems.
KEY SCIENTIFIC CONCEPTS OF REVIEW: The manuscript outlines the evolution of detection methodologies from early biotin-switch assays to Quantitative Thiol Reactivity Profiling. Mechanistically, S-persulfidation modulates membrane potential and vascular tone by altering the open probability of ion channels including KATP and Cav1.2. At the intracellular level, this modification regulates kinase cascades, redox sensors such as the Keap1/Nrf2 pathway, and metabolic enzymes to preserve mitochondrial bioenergetics. S-persulfidation also orchestrates genomic and post-transcriptional programs by directly modifying transcription factors and RNA-binding proteins. Furthermore, it reinforces the cellular protein quality control system to alleviate endoplasmic reticulum stress, optimize autophagy, and establish inhibitory checkpoints against apoptosis and pyroptosis. The review also evaluates systemic delivery vectors, including S-persulfidated albumin and engineered biomaterial scaffolds. Overcoming current translational barriers requires integrating spatial multi-omics with site-specific genetic validation to advance S-persulfidation biology toward precise cardiovascular therapeutics.